Related Experiment Video
Updated: Jun 26, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS
Clement Y Chow1, John E Landers, Sarah K Bergren
1Department of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
Mutations of the lipid phosphatase FIG4 that regulates PI(3,5)P(2) are responsible for the recessive peripheral-nerve disorder CMT4J. We now describe nonsynonymous variants of FIG4 in 2% (9/473) of patients with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS). Heterozygosity for a deleterious allele of FIG4 appears to be a risk factor for ALS and PLS, extending the list of known ALS genes and increasing the clinical spectrum of FIG4-related diseases.
Insights
Mutations in the FIG4 gene, previously linked to CMT4J, are found in some patients with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS). This suggests FIG4 variants are a risk factor for these neurodegenerative diseases.
Area of Science:
- Neurogenetics
- Molecular Biology
- Cellular Biology
Background:
- The lipid phosphatase FIG4 regulates PI(3,5)P(2) and its mutations cause the peripheral neuropathy CMT4J.
- Amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) are progressive neurodegenerative conditions affecting motor neurons.
Purpose of the Study:
- To investigate the role of FIG4 gene variants in patients diagnosed with ALS and PLS.
- To determine if heterozygosity for FIG4 alleles constitutes a risk factor for ALS and PLS.
Main Methods:
- Genetic sequencing of the FIG4 gene in a cohort of patients with ALS and PLS.
- Analysis of nonsynonymous variants identified in the FIG4 gene.
Main Results:
- Nonsynonymous variants in the FIG4 gene were identified in 2% (9/473) of patients with ALS and PLS.
- Deleterious alleles of FIG4 were found to be associated with an increased risk of developing ALS and PLS.
Conclusions:
- The FIG4 gene is implicated in the pathogenesis of ALS and PLS, expanding its known clinical spectrum beyond CMT4J.
- Genetic variations in FIG4 represent a novel risk factor for ALS and PLS, contributing to the understanding of these complex diseases.
More Related Videos
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Lysosomal Hydrolases
Alzheimer Disease l: Introduction
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...